AlzeCure Pharma AB (publ) (STO:ALZCUR)

AlzeCure Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	32.97	50.34	31.5	29.1	25.58	41.74
Cash & Short-Term Investments	32.97	50.34	31.5	29.1	25.58	41.74
Cash Growth	58.35%	59.81%	8.24%	13.77%	-38.73%	-62.88%
Accounts Receivable	-	0	0.04	0	-	-
Other Receivables	2.55	3.34	1.77	1.47	1.38	1.54
Total Trade Receivables	2.55	3.34	1.8	1.47	1.38	1.54
Other Current Assets	1.49	1.28	0.61	1.04	43.01	0.92
Total Current Assets	37.01	54.96	33.9	31.61	27.51	44.2
Net Property, Plant & Equipment	3.78	4.06	5.33	0.38	0.85	1.42
Other Intangible Assets	0.02	0.02	0.02	0.02	0.02	0.02
Other Long-Term Assets	-	-	-	-	0.01	0.01
Total Assets	40.81	59.04	39.25	32	70.84	45.65

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	6.54	4.16	2.69	2.69	4.85	5.97
Accrued Expenses	10.33	6.67	5.25	4.95	5.18	6.38
Other Current Liabilities	10.42	12.74	1.61	0.59	0.33	0.32
Total Current Liabilities	27.29	23.56	9.55	8.23	10.35	12.67
Long-Term Leases	2.29	2.56	3.64	-	-	-
Total Long-Term Liabilities	2.29	2.56	3.64	-	-	-
Total Liabilities	29.58	26.12	13.18	8.23	10.35	12.67

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	2.87	2.87	2.21	1.55	1.55	0.94
Additional Paid-in Capital	453.27	453.27	399.43	362.44	361.98	278.84
Retained Earnings	-444.92	-423.22	-375.57	-340.22	-303.05	-246.81
Shareholders' Equity	11.23	32.92	26.07	23.77	60.48	32.97
Total Liabilities & Equity	40.81	59.04	39.25	32	70.84	45.65

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	2.29	2.56	3.64	0	0	0
Net Cash (Debt)	30.68	47.78	27.86	29.1	25.58	41.74
Net Cash Growth	75.82%	71.47%	-4.25%	13.77%	-38.73%	-62.88%
Net Cash Per Share	0.29	0.47	0.36	0.47	0.53	1.09
Book Value	11.23	32.92	26.07	23.77	60.48	32.97
Book Value Per Share	0.10	0.33	0.34	0.38	1.26	0.86
Tangible Book Value	11.21	32.9	26.05	23.76	60.47	32.96
Tangible Book Value Per Share	0.10	0.33	0.34	0.38	1.26	0.86

Data Source: Fiscal.ai Last updated: May 5, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 10, 2026

Data Sources Report a data error